Pacira Pharmaceuticals buy melinda
Start price
22.03.17
/
50%
€42.17
Target price
26.04.17
€80.28
Performance (%)
0.53%
End price
26.04.17
€42.39
Summary
This prediction ended on 26.04.17 with a price of €42.39. During the runtime of the prediction for Pacira Pharmaceuticals the price only changed by 0.53%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pacira Pharmaceuticals | 6.707% | 6.707% | -29.435% | -53.704% |
| iShares Core DAX® | 0,19 % | -1,22 % | 8,84 % | 58,52 % |
| iShares Nasdaq 100 | -1,35 % | -5,31 % | -1,14 % | 82,23 % |
| iShares Nikkei 225® | -0,43 % | 7,32 % | 27,58 % | 65,21 % |
| iShares S&P 500 | -1,01 % | -3,40 % | -0,22 % | 56,66 % |
Comments by melinda for this prediction
In the thread Pacira Pharmaceuticals diskutieren
$ PCRX bekräftigt mit einem Outperform bei Wedbush. $ 89 PT
A +
Stopped prediction by melinda for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€35.51
29.01.19
29.01.19
€42.39
02.05.19
02.05.19
19.77%
02.05.19
02.05.19
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€36.31
27.08.16
27.08.16
€40.59
27.02.17
27.02.17
7.95%
27.02.17
27.02.17
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€36.95
19.10.15
19.10.15
€63.14
15.12.15
15.12.15
78.88%
15.12.15
15.12.15